Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

Background: Anastomotic recurrence is frequent in patients with Crohn’s disease (CD) following ileocecal resection. The degree of endoscopic recurrence, quantified by the Rutgeerts score (RS), correlates with risk of clinical and surgical recurrence. Several studies demonstrate the accuracy of fecal...

Full description

Bibliographic Details
Main Authors:	Yuen Sau Tham, Diana E. Yung, Shmuel Fay, Takayuki Yamamoto, Shomron Ben-Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-06-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/1756284818785571

Similar Items

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
by: Doron Yablecovitch, et al.
Published: (2018-01-01)

Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
by: Juan María Vázquez-Morón, et al.

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
by: Dan Carter, et al.
Published: (2018-03-01)

Calprotectina fecal Fecal calprotectin
by: L. Rodrigo
Published: (2007-12-01)

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
by: Alexander S. Somwaru, et al.
Published: (2019-12-01)

Fecal calprotectin and microbiota of the gut
by: V. G. Gorokhova, et al.
Published: (2016-07-01)

Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn’s disease: a long-term prospective study
by: Takayuki Yamamoto, et al.
Published: (2016-09-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

The role of fecal calprotectin in pediatric disease
by: Su Jin Jeong
Published: (2019-08-01)

Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer
by: Borza Ioan Lucian, et al.
Published: (2015-03-01)

A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation
by: Noa Rozendorn, et al.
Published: (2018-04-01)

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
by: Francisco Guilherme Cancela e Penna, et al.
Published: (2020-02-01)

Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease
by: Juan Egea-Valenzuela, et al.

Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.
by: Arno R Bourgonje, et al.
Published: (2018-01-01)

Fecal Calprotectin Level in Neonates with Necrotizing Enterocolitis
by: Maha Abdelkader, et al.
Published: (2019-09-01)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01)

Value of Fecal Calprotectin in Rotavirus Infection in Infants
by: O.Ye. Abaturov, et al.
Published: (2014-11-01)

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
by: Jennifer Wang, et al.
Published: (2021-01-01)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
by: Arno R. Bourgonje, et al.
Published: (2019-09-01)

The impact of panenteric capsule endoscopy on the management of Crohn’s disease
by: Rami Eliakim
Published: (2017-09-01)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
by: Renske W. M. Pauwels, et al.
Published: (2020-12-01)

Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
by: Dimitrios C Ziogas
Published: (2021-03-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Fecal calprotectin in the differential diagnosis of acute intestinal infections
by: E. D. Vlkova, et al.
Published: (2018-07-01)

Fecal calprotectin concentration in the differential diagnosis of bowel diseases
by: M F Osipenko, et al.
Published: (2015-02-01)

Age-Related Fecal Calprotectin Concentrations in Healthy Adults
by: Shin Young Park
Published: (2020-09-01)

Fecal calprotectin and its association with functional dyspepsia in children
by: Jeanette Manoppo, et al.
Published: (2020-03-01)

A Study of Fecal Calprotectin in Obese Children and Adults
by: Shin Young Park, et al.
Published: (2018-12-01)

Evaluation of ELISA and rapid test for the analysis of fecal Calprotectin
by: Albeer, Merna
Published: (2013)

The role of fecal calprotectin in investigating inflammatory bowel diseases
by: Mustafa Erbayrak, et al.
Published: (2009-05-01)

Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
by: Hussein Mahajna, et al.
Published: (2020-11-01)

Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
by: Ebby George Simon, et al.
Published: (2019-04-01)

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
by: Ido Veisman, et al.
Published: (2021-09-01)

Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study
by: Lukasz Kwapisz, et al.
Published: (2015-01-01)

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes
by: Rossini Lucio, et al.
Published: (2009-10-01)

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
by: Anna Strömbeck, et al.
Published: (2020-05-01)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
by: Yang Woon Lee, et al.
Published: (2019-01-01)

Dynamic Changes of Fecal Calprotectin and Related Clinical Factors in Neonates
by: Ji Sook Park, et al.
Published: (2020-07-01)

Fecal calprotectin in healthy children aged 4–16 years
by: María Roca, et al.
Published: (2020-11-01)